Pyrroloquinolinyl-pyrrolidine-2,5-dione formulations and methods for preparing and using same

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9180099
APP PUB NO 20130011481A1
SERIAL NO

13543007

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides pyrroloquinolinyl-pyrrole-2,5-dione formulations and methods of treating a cell proliferative disorder, such as a cancer, by administering to a subject in need thereof a therapeutically effective amount of the formulations containing pyrroloquinolinyl-pyrrole-2,5-dione compounds.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ARQULE INC200 BOSTON AVENUE MEDFORD MA 02155

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Kato, Takafumi Kanagawa, JP 38 447
Yamakose, Hiroshi Kanagawa, JP 34 293

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 10, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00